D'Andrea D, Shariat SF. Re: M. Roupret, A. Bertaut, G. Pignot, et al. ALBAN (GETUG-AFU 37): A Phase 3, Randomized, Open-label, International Trial of Intravenous Atezolizumab and Intravesical Bacillus Calmette-Guerin (BCG) Versus BCG Alone in BCG-naive High-risk, Non-muscle- Eur Urol Oncol 2025 Dec 15:S2588-9311(25)00329.
PMID: 41402160